article thumbnail

Big pharma companies partner to form AI-based start-up

pharmaphorum

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. At times, companies invest millions of dollars in developing and studying a therapy that may find to be ineffective. The partnership.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Country focus: Hungary carves out a niche in digital pharma

pharmaphorum

They go into bioinformatics”. In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We They go into bioinformatics.”. So what do they do?

article thumbnail

Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s

pharmaphorum

The trial – which will be supported by pharma company Eisai and Ionian University in the US – will see if the test can identify people who have mild cognitive impairment (MCI) due to Alzheimer’s disease.

Trials 78
article thumbnail

How digital is transforming the commercial leader’s role in biopharma

pharmaphorum

To compete now, companies need to own a larger portion of the treatment journey and the overall patient care experience. Commercial leaders should leverage the internal capabilities and centres of excellence that pharma companies are increasingly building.

Marketing 133
article thumbnail

Sandoz, Ares extend digital alliance on antimicrobial resistance

pharmaphorum

During the initial stage of the collaboration, Ares developed a an AI-powered anti-infectives platform using microbiological lab techniques and bioinformatics that can be used to identify effective antimicrobial compounds or combinations against specific pathogens, which Sandoz can use to inform its “portfolio and commercial decisions.”

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

data processing systems that support bioinformatics modelling) and digital record systems (e.g. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. Digital technologies can cover a broad range of applications, and include mobile health (mHealth) tools (e.g.